Emmanuel J Favaloro/LinkedIn
Dec 16, 2025, 13:00
ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn:
“The ScholarGPS database has been updated. Honored to be ranked No. 1 in the World in lifetime category for the field of Hemostasis; 4th in the world for both Thrombosis and von Willebrand disease. Take a look to see if you are on the list.”
-
Jun 29, 2026, 20:09Mamta Soni: The Role of Anti-Xa Monitoring in Anticoagulation Management
-
Jun 29, 2026, 20:07Nita Radhakrishnan: Discussing Risks, Benefits, and Uncertainties in Hemoglobinopathy Care
-
Jun 29, 2026, 20:05Anisha Navkudkar: TMH Blood Centre Received the Ravi Reddy Award 2026 at ISBT Congress
-
Jun 29, 2026, 20:03Anirban Sen Gupta: Congratulations Christopher Delianides for a Fantastic Dissertation and Graduate Research Presentation
-
Jun 29, 2026, 20:01May Guo: Inhibiting Anti-PEG Antibody Binding With Randomized PEG
-
Jun 29, 2026, 15:50Sweta Agrawal: Expanding Care for PNH Patients in Nepal
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice